Inflammatory comorbidities ın the largest pediatric Familial Mediterranean fever cohort: a multicenter retrospective study of Pediatric Rheumatology Academy (PeRA)-Research Group (RG)

Aim The aim of this study was to investigate the frequency and type of FMF-associated inflammatory diseases in a large FMF pediatric patients and to compare them to those FMF patients without concomitant inflammatory diseases. Materials and methods Familial Mediterranean fever patients enrolled in t...

Full description

Saved in:
Bibliographic Details
Published in:Clinical rheumatology 2024, Vol.43 (1), p.407-413
Main Authors: Ozdel, Semanur, Coşkuner, Taner, Demirkan, Fatmagül, Torun, Rüya, Aydın, Elif Arslanoglu, Bağlan, Esra, Yener, Gülçin Otar, Öztürk, Kübra, Demir, Ferhat, Karadağ, Şerife Gül, Çakan, Mustafa, Sönmez, Hafize Emine, Makay, Balahan Bora, Ünsal, Şevket Erbil, Bülbül, Mehmet, Ayaz, Nuray Aktay, Sözeri, Betül
Format: Article
Language:English
Subjects:
Amyloidosis
Arthritis
Arthritis, Juvenile - drug therapy
Child
Colchicine
Colchicine - therapeutic use
Comorbidity
Erysipelas
Erythema
Familial Mediterranean fever
Familial Mediterranean Fever - complications
Familial Mediterranean Fever - drug therapy
Familial Mediterranean Fever - epidemiology
Fever
Humans
Inflammatory diseases
Medicine
Medicine & Public Health
Mutation
Original Article
Pain
Patients
Pediatrics
Pyrin - genetics
Retrospective Studies
Rheumatology
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Aim The aim of this study was to investigate the frequency and type of FMF-associated inflammatory diseases in a large FMF pediatric patients and to compare them to those FMF patients without concomitant inflammatory diseases. Materials and methods Familial Mediterranean fever patients enrolled in the Pediatric Rheumatology Academy (PeRA)-Research Group (RG) were included. The patients were divided into two groups according to concomitant inflammatory disease as FMF patients who had a concomitant inflammatory disease (group 1) and FMF patients who did not have a concomitant inflammatory disease (group 1). The clinical findings and treatments were compared between the two groups. Results The study group comprised 3475 patients with FMF. There were 294 patients (8.5%) in group 1 and 3181 patients (91.5%) in group 2. Juvenile idiopathic arthritis ( n  = 136) was the most common accompanying inflammatory disease. Arthritis, M694V homozygosity, and the need for biological therapy were more frequently observed in Group 1 ( p  
ISSN:0770-3198
1434-9949
DOI:10.1007/s10067-023-06802-6